Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hooper

Showing results (161-170 of 201) with videos related to

Pageof 21
Sort By:
Frontiers in Microbiology|June 9, 2020
Anti-HFRS Human IgG Produced in Transchromosomic Bovines Has Potent Hantavirus Neutralizing Activity and Is Protective in Animal ModelsCasey C Perley, Rebecca L Brocato, Hua Wu, et al.
Human Vaccines & Immunotherapeutics|May 22, 2015
Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challengesRebecca J Grant-Klein, Louis A Altamura, Catherine V Badger, et al.
Journal of the American Chemical Society|March 19, 2025
Heteroepitaxial Growth of Narrow Band Gap Carbon-Rich Carbon Nitride Using In Situ Polymerization to Empower Sunlight-Driven Photoelectrochemical Water SplittingNarendra Chaulagain, Kazi M Alam, John C Garcia, et al.
Viral Immunology|December 17, 2014
Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoproteinKaren Martins, John H Carra, Christopher L Cooper, et al.
NPJ Vaccines|November 17, 2024
Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injectionJay W Hooper, Steven A Kwilas, Matthew Josleyn, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 3, 2023
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durabilityAngela Huttner, Selidji Todagbe Agnandji, Olivier Engler, et al.
Viruses|March 27, 2025
rVSVΔG-ZEBOV-GP Vaccine Is Highly Immunogenic and Efficacious Across a Wide Dose Range in a Nonhuman Primate EBOV Challenge ModelAmy C Shurtleff, John C Trefry, Sheri Dubey, et al.
The Journal of Infectious Diseases|June 12, 2015
Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and FilovirusesMallory Willet, Drishya Kurup, Amy Papaneri, et al.
Plos One|October 1, 2015
Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan EbolavirusesCallie E Bounds, Steven A Kwilas, Ana I Kuehne, et al.
Frontiers in Immunology|July 10, 2025
Immune responses following DNA vaccination by needle-free injection against <i>Burkholderia pseudomallei</i> hemolysin co-regulated protein 1Michael L Davies, Sergei S Biryukov, Christopher P Klimko, et al.
Pageof 21

Showing results (161-170 of 201) with videos related to

Sort By:
Pageof 21
Frontiers in Microbiology|June 9, 2020
Anti-HFRS Human IgG Produced in Transchromosomic Bovines Has Potent Hantavirus Neutralizing Activity and Is Protective in Animal ModelsCasey C Perley, Rebecca L Brocato, Hua Wu, et al.
Human Vaccines & Immunotherapeutics|May 22, 2015
Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challengesRebecca J Grant-Klein, Louis A Altamura, Catherine V Badger, et al.
Journal of the American Chemical Society|March 19, 2025
Heteroepitaxial Growth of Narrow Band Gap Carbon-Rich Carbon Nitride Using In Situ Polymerization to Empower Sunlight-Driven Photoelectrochemical Water SplittingNarendra Chaulagain, Kazi M Alam, John C Garcia, et al.
Viral Immunology|December 17, 2014
Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoproteinKaren Martins, John H Carra, Christopher L Cooper, et al.
NPJ Vaccines|November 17, 2024
Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injectionJay W Hooper, Steven A Kwilas, Matthew Josleyn, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 3, 2023
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durabilityAngela Huttner, Selidji Todagbe Agnandji, Olivier Engler, et al.
Viruses|March 27, 2025
rVSVΔG-ZEBOV-GP Vaccine Is Highly Immunogenic and Efficacious Across a Wide Dose Range in a Nonhuman Primate EBOV Challenge ModelAmy C Shurtleff, John C Trefry, Sheri Dubey, et al.
The Journal of Infectious Diseases|June 12, 2015
Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and FilovirusesMallory Willet, Drishya Kurup, Amy Papaneri, et al.
Plos One|October 1, 2015
Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan EbolavirusesCallie E Bounds, Steven A Kwilas, Ana I Kuehne, et al.
Frontiers in Immunology|July 10, 2025
Immune responses following DNA vaccination by needle-free injection against <i>Burkholderia pseudomallei</i> hemolysin co-regulated protein 1Michael L Davies, Sergei S Biryukov, Christopher P Klimko, et al.
Pageof 21